Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,806,748
  • Shares Outstanding, K 44,877
  • Annual Sales, $ 1,185 M
  • Annual Income, $ 2,050 K
  • EBIT $ 5 M
  • EBITDA $ 94 M
  • 60-Month Beta 0.78
  • Price/Sales 1.46
  • Price/Cash Flow 13.97
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 52.86% (+7.26%)
  • Historical Volatility 64.93%
  • IV Percentile 39%
  • IV Rank 30.38%
  • IV High 89.58% on 04/08/25
  • IV Low 36.84% on 09/02/25
  • Expected Move (DTE 25) 5.27 (13.32%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 27
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 950
  • Open Int (30-Day) 1,366
  • Expected Range 34.29 to 44.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.15
  • Number of Estimates 3
  • High Estimate 0.21
  • Low Estimate 0.09
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +87.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.38 +11.81%
on 02/09/26
50.99 -22.42%
on 01/26/26
-10.74 (-21.35%)
since 01/23/26
3-Month
34.78 +13.73%
on 11/25/25
55.00 -28.07%
on 01/13/26
+3.56 (+9.89%)
since 11/21/25
52-Week
22.66 +74.58%
on 05/06/25
55.00 -28.07%
on 01/13/26
-0.16 (-0.40%)
since 02/21/25

Most Recent Stories

More News
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 94.42 (-8.42%)
OMCL : 39.56 (-1.74%)
PACB : 1.5800 (-1.86%)
ALGN : 181.26 (-4.61%)
QDEL : 21.19 (-5.74%)
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

OMCL : 39.56 (-1.74%)
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL : 39.56 (-1.74%)
Why Omnicell (OMCL) Shares Are Plunging Today

Why Omnicell (OMCL) Shares Are Plunging Today

OMCL : 39.56 (-1.74%)
Omnicell: Q4 Earnings Snapshot

Omnicell: Q4 Earnings Snapshot

OMCL : 39.56 (-1.74%)
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

OMCL : 39.56 (-1.74%)
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Omnicell delivers solid fourth quarter 2025 financial results A nnounces major step toward autonomous medication management with the launch of its next generation...

OMCL : 39.56 (-1.74%)
Omnicell Earnings: What To Look For From OMCL

Omnicell Earnings: What To Look For From OMCL

OMCL : 39.56 (-1.74%)
Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

OMCL : 39.56 (-1.74%)
1 Healthcare Stock to Consider Right Now and 2 We Brush Off

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

OMCL : 39.56 (-1.74%)
SUPN : 50.69 (-0.33%)
VRTX : 481.01 (+0.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 41.21
2nd Resistance Point 40.52
1st Resistance Point 40.04
Last Price 39.56
1st Support Level 38.87
2nd Support Level 38.18
3rd Support Level 37.70

See More

52-Week High 55.00
Fibonacci 61.8% 42.65
Last Price 39.56
Fibonacci 50% 38.83
Fibonacci 38.2% 35.01
52-Week Low 22.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar